Peripheral Neuropathy in Post Stroke Patients

February 9, 2018

 

Challenge

Meet time-sensitive enrollment goal of 496 patients in order to extend labeling for client’s FDA-approved neurostimulation device for the treatment of peripheral neuropathy in post-stroke patients.

Solution

ThreeWire developed an comprehensive solution to maximize enrollment that included a detailed media outreach campaign tailored to each site’s unique needs. ThreeWire also created a study-specific website with self-screener. Respondents were prescreened in our Patient Interaction Center® (PIC) before being referred to sites. ThreeWire’s Site Services group ensured that each site received the proper number of referrals and processed each patient through to enrollment.

Results

ThreeWire contributed 204 patients, or 42% of the total enrollment goal. Our high-quality prescreening process and site services were key factors in allowing us to close enrollment ahead of schedule and under budget.

Previous Flipbook
Patient Retention for Phase IIB OAB Drug Across Six Continents
Patient Retention for Phase IIB OAB Drug Across Six Continents

Challenge: Retain 700 subjects who completed the first part of the study into a 52-week extension study acr...

Next Flipbook
Pivotal Implant Study-Drug Refractory Epilepsy
Pivotal Implant Study-Drug Refractory Epilepsy

Challenge ThreeWire was called on to assist the sponsor with completing enrollment ahead of multiple compet...